The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
5948 - Jardiance® (empagliflozin) tablets: A Review of Multiple Clinical Trials and Approved Indications—Presented by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA